Search

Your search keyword '"Bristol-Myers Squibb Co. -- Forecasts and trends"' showing total 1,053 results

Search Constraints

Start Over You searched for: Descriptor "Bristol-Myers Squibb Co. -- Forecasts and trends" Remove constraint Descriptor: "Bristol-Myers Squibb Co. -- Forecasts and trends"
1,053 results on '"Bristol-Myers Squibb Co. -- Forecasts and trends"'

Search Results

1. What's Behind the Insider Buying on This High-Yield Stock?

2. Brain Tumor Therapeutics Global Research Business Report 2024-2030 Featuring Profiles of Market Leaders Including AstraZeneca, Bristol-Myers Squibb, DelMar Pharmaceuticals

3. CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period (2020-2034) | DelveInsight

4. Alpha Thalassemia Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Agios Pharma, Novo Nordisk, Bristol-Myers Squibb, Genmedicn Biopharma

5. Her2+ Gastric Cancer Market Report 2032: Epidemiology Insights, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Roche, Elevar Therapeutic, Bristol-Myers Squibb, Merck, Daiichi Sa

6. Progressive Pulmonary Fibrosis Market Size in the 7MM was USD 1,300 Million in 2023, estimated DelveInsight

7. Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, Regeneron

8. United States Leads Global Pancreatic Cancer Market with 50% Share, Surpassing EU4, UK, and Japan, Reports DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, BMS

9. Psoriasis Market is expected to rise at a significant CAGR, DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb

10. Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight

11. CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Market on Track for Major Expansion by 2034, According to DelveInsight | Eli Lilly and Company, Gilead Sciences, Novartis, Autolus Therapeutics

12. Cell and Gene Therapy Market to Grow by USD 6.56 Billion (2024-2028), Driven by Rising Prevalence of Chronic Diseases, AI-Powered Report Explores Market Evolution - Technavio

13. Acute Ischemic Stroke Market on Track for Major Expansion by 2034, According to DelveInsight | Abbvie, Acticor Biotech, Athersys, Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics

14. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio

15. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio

16. Anti-CD38 mAb Market to Accelerate Substantially During the Study Period (2020-2034) Owing to a Strong Uptake of DARZALEX in Multiple Myeloma and Expected Entry of anti-CD38 mAbs in Autoimmune Diseases | DelveInsight

17. Anti-CD38 mAb Market to Accelerate Substantially During the Study Period (2020-2034) Owing to a Strong Uptake of DARZALEX in Multiple Myeloma and Expected Entry of anti-CD38 mAbs in Autoimmune Diseases | DelveInsight

18. Adrenal crisis Market on Track for Major Expansion by 2034, According to DelveInsight | Takeda Pharma, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma

19. Postpartum Depression Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | SAGE Therapeutics, GH Research, Bristol-Myers Squibb

20. Hypertrophic Cardiomyopathy Treatment Market Size in the 7MM was ~USD 646 Million in 2023, estimated DelveInsight

21. Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing

22. The immunology market is projected to grow by USD 65.8 Billion from 2024-2028, with AI reshaping the landscape and increasing organ transplants driving revenue - Technavio

23. Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, Asserts DelveInsight | Pfizer, Astellas Pharma, Bristol-Myers Squibb, Laekna Therapeutics, Novartis

24. United States Dominates Global Pancreatic Cancer Market with 50% Share, Outpacing EU4, UK, and Japan, DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, Bristol Myers Squibb

25. Psoriasis Market is anticipated to rise at a notable CAGR, estimates DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb

26. Global Cancer Monoclonal Antibodies Market to Cross ~USD 157 Billion Mark by 2030 | DelveInsight

27. Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsight

28. BCMA-Targeted Therapies Market to Witness Upsurge in Growth During the Study Period (2020-2034) | DelveInsight

29. Celiac Diseases Drugs Market size is set to grow by USD 1.10 billion from 2024-2028, Higher consumption of gluten-containing food boost the market

30. Celiac Diseases Drugs Market size is set to grow by USD 1.10 billion from 2024-2028, Higher consumption of gluten-containing food boost the market, Technavio

31. Sarcoma Therapeutics Market size is set to grow by USD 1.11 billion from 2024-2028, Patient assistance programs boost the market, Technavio

32. Stock Market Outlook for Friday Today

33. Head and Neck Cancer Treatment Market size is set to grow by USD 7.12 billion from 2024-2028, Increasing incidence of head and neck cancers boost the market, Technavio

34. Car T-Cell Therapy Market size is set to grow by USD 3.02 billion from 2024-2028, Growing awareness regarding car T-cell therapy to boost the market growth, Technavio

35. Technavio predicts increase in global peptide therapeutics market size

36. Technavio predicts increase in global peptide therapeutics market size

37. Technavio predicts global autism spectrum disorder therapeutics market to increase in size

38. Technavio predicts global autism spectrum disorder therapeutics market to increase in size

39. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

40. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

41. Global Autologous Stem Cell & Non-stem Cell Therapies Market Report 2024-2029, with Comparative Analysis of Cupistem Efficacy in Treatment of Crohn's Perianal Fistulas

42. AstraZeneca: Price Upside Is Over (Rating Downgrade)

43. Checkpoint Inhibitor Refractory Cancer Market Size in the 7MM is expected to grow by 2032, estimates DelveInsight

44. NSCLC Market Size in the 7MM is expected to Grow by 2032, estimates DelveInsight

45. Ischemic Stroke Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight

46. Protein Therapeutics Market size is set to grow by USD 172.8 billion from 2024-2028, Increased demand for mAbs boost the market, Technavio

47. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market size is set to grow by USD 11.66 billion from 2024-2028, High target affinity and specificity of VEGF inhibitors to boost the market growth, Technavio

48. PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-2034, eatimates DelveInsight | Isunakinra, Dato-DXd, ONC-392, ZYNYZ (retifanlimab), Spartalizumab (PDR001), more

49. Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis

50. Multiple Sclerosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis AG, Sanofi, F. Hoffmann-La Roche, Celgene Crp., Johnson & Johnson

Catalog

Books, media, physical & digital resources